Catalyst Pharma's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Catalyst Pharma is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is €0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 110.57M	$ 102.69M	$ 99.48M	$ 85.37M	$ 60.76M
Gross Profit	$ 94.76M	$ 88.52M	$ 87.54M	$ 75.42M	$ 49.56M
EBIT	$ 46.71M	$ -38.02M	$ 48.51M	$ 37.31M	$ 33.01M
EBITDA	$ 55.85M	$ -29.45M	$ 57.08M	$ 43.91M	$ 33.64M
Net Income Common Stockholders	$ 34.84M	$ -22.28M	$ 37.76M	$ 29.57M	$ 25.47M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 137.64M	$ 120.97M	$ 178.79M	$ 148.25M	$ 298.39M
Total Assets	$ 470.11M	$ 413.21M	$ 443.90M	$ 405.94M	$ 375.63M
Total Debt	$ 3.19M	$ 3.28M	$ 3.38M	$ 3.47M	$ 3.56M
Net Debt	$ -134.45M	$ -117.69M	$ -175.41M	$ -144.78M	$ -294.84M
Total Liabilities	$ 82.23M	$ 64.66M	$ 68.60M	$ 73.57M	$ 75.21M
Stockholders Equity	$ 387.88M	$ 348.55M	$ 375.29M	$ 333.66M	$ 300.42M
Cash Flow	-
Free Cash Flow	$ 55.55M	$ 45.06M	$ 30.75M	$ 12.00M	$ 40.08M
Operating Cash Flow	$ 55.65M	$ 45.13M	$ 30.75M	$ 12.07M	$ 40.08M
Investing Cash Flow	$ -38.32M	$ -92.82M	-	$ -162.37M	-
Financing Cash Flow	$ -665.00K	$ -10.13M	$ -214.00K	$ 149.00K	$ 2.25M

Currency in USD

Catalyst Pharma Earnings and Revenue History

Income Statement >

Catalyst Pharma Debt to Assets

Balance Sheet >

Catalyst Pharma Cash Flow

Cash Flow >

Catalyst Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing